SCHEMBL29352425

SCHEMBL29352425

O=C(O)c1ccccc1C1c2cc(Cl)c(O)cc2Oc2cc(O)c(Cl)cc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.61
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
CASP6 P55212 2/20 0.46
ALDH1A1 P00352 5/20 0.41
FTO Q9C0B1 1/20 0.40
GAA P10253 1/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA12 O43570 1/20 0.39
HMGB1 P09429 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA7 P43166 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA9 Q16790 1/20 0.39
NAPRT Q6XQN6 1/20 0.39
CA14 Q9ULX7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31214032 1.00 CYP2C9 (0.61) CYP2C9MEN1KMT2ACASP6ALDH1A1
SCHEMBL621657 1.00 CYP2C9 (0.61) CYP2C9MEN1KMT2ACASP6ALDH1A1
SCHEMBL29390730 0.94 CYP2C9 (0.61) CYP2C9MEN1KMT2ACASP6ALDH1A1
SCHEMBL619746 0.83 CYP2C9 (0.61) CYP2C9MEN1KMT2ACASP6ALDH1A1
SCHEMBL1507702 0.80 CYP2C9 (0.69) CYP2C9ALDH1A1GAAKDM4ECA1
SCHEMBL29352348 0.80 CYP2C9 (0.53) CYP2C9MEN1KMT2AALDH1A1GAA
SCHEMBL12361545 0.80 CYP2C9 (0.53) CYP2C9MEN1KMT2AALDH1A1GAA
SCHEMBL30467958 0.80 CYP2C9 (0.53) CYP2C9MEN1KMT2AALDH1A1GAA
SCHEMBL8772390 0.79 MEN1 (0.49) MEN1KMT2ACASP6ALDH1A1GAA
Fluorescin SCHEMBL27403 0.78 CYP2C9 (0.71) CYP2C9MEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114200065-B Method for quantitatively measuring content of in vivo/in vitro superoxide radical generated by environmental stress 维塔探索(广东)科技有限公司 2022-07-26 CN claimed
CN-114748062-A Light-operated virtual micro sensor and preparation method and application thereof 暨南大学 2022-07-15 CN claimed
CN-114200065-A Method for quantitatively measuring content of in vivo/in vitro superoxide radical generated by environmental stress 维塔探索(广东)科技有限公司 2022-03-18 CN claimed
EP-4594288-A2 METHOD OF TREATING NEURODEGENERATIVE DISEASES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2025-08-06 EP disclosed
CN-119639458-A Fluorescent carbon nano-dot with I-type PDT effect and preparation method and application thereof 复旦大学 2025-03-18 CN disclosed
CN-114748062-B Light-operated virtual microsensor and preparation method and application thereof 暨南大学 2024-08-06 CN disclosed
CN-115844979-B Traditional Chinese medicine composition for nourishing primordial qi and strengthening brain, soothing nerves and improving intelligence as well as preparation method and application thereof 湖北中医药大学 2024-07-19 CN disclosed
WO-2024073131-A2 METHOD OF TREATING NEURODEGENERATIVE DISEASES THE BOARD OF TRUSTEES OF THE UNIVESITY OF ILLINOIS (US) 2024-04-04 WO disclosed
CN-114805447-B Iridium complex photosensitizer and preparation method and application thereof 兰州大学 2023-11-24 CN disclosed
CN-114149362-B Application of hemicyanine micromolecule compound as fluorescent probe and photodynamic antibacterial agent 北京工商大学 2023-09-08 CN disclosed
US-11560360-B2 Therapeutic compounds ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2023-01-24 US disclosed
EP-4051381-A1 COMPOSITIONS FOR THE CARDIOVASCULAR RISK REDUCTION Neilos S.r.l. (IT) 2022-09-07 EP disclosed
CN-114989189-A Compound with aggregation-induced emission performance and preparation method and application thereof 西南交通大学 2022-09-02 CN disclosed
CN-114200065-B Method for quantitatively measuring content of in vivo/in vitro superoxide radical generated by environmental stress 维塔探索(广东)科技有限公司 2022-07-26 CN disclosed
CN-114748062-A Light-operated virtual micro sensor and preparation method and application thereof 暨南大学 2022-07-15 CN disclosed
EP-3998875-A1 AEROSOL-GENERATING ARTICLE SUITABLE FOR USE IN AN AEROSOL-GENERATING DEVICE Bio-On S.p.A. (IT) 2022-05-25 EP disclosed
EP-3975766-A1 FILTER ELEMENT SUITABLE FOR USE IN A SMOKING ARTICLE AND PROCESS FOR PRODUCING THE SAME Bio-On S.p.A. (IT) 2022-04-06 EP disclosed
CN-114200065-A Method for quantitatively measuring content of in vivo/in vitro superoxide radical generated by environmental stress 维塔探索(广东)科技有限公司 2022-03-18 CN disclosed
CN-114149362-A Application of hemicyanine micromolecular compound as fluorescent probe and photodynamic antibacterial agent 北京工商大学 2022-03-08 CN disclosed
CN-113956190-A Organelle targeted photosensitizer capable of activating tumor cell apoptosis and preparation method and application thereof 大连理工大学 2022-01-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11560360-B2 Therapeutic compounds CFTR, MC2R, RPS21 CYP2C9 1223/4885MEN1 366/4885KMT2A 3694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.